statistiche ricercatore

Continente	#
NA - Nord America	3.726
AS - Asia	506
EU - Europa	379
SA - Sud America	98
AF - Africa	12
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	2
Totale	4.726

Nazione	#
US - Stati Uniti d'America	3.694
SG - Singapore	159
CN - Cina	153
RU - Federazione Russa	117
IT - Italia	100
BR - Brasile	72
VN - Vietnam	49
FI - Finlandia	38
BD - Bangladesh	36
HK - Hong Kong	31
GB - Regno Unito	28
DE - Germania	23
CA - Canada	19
FR - Francia	16
IN - India	14
AE - Emirati Arabi Uniti	13
PL - Polonia	12
SE - Svezia	11
JP - Giappone	10
NL - Olanda	9
MX - Messico	8
CO - Colombia	7
IE - Irlanda	7
TR - Turchia	7
IQ - Iraq	6
ZA - Sudafrica	5
AR - Argentina	4
EC - Ecuador	4
ES - Italia	4
MY - Malesia	4
SA - Arabia Saudita	4
AT - Austria	3
BE - Belgio	3
CL - Cile	3
ID - Indonesia	3
IL - Israele	3
LT - Lituania	3
PY - Paraguay	3
CR - Costa Rica	2
EG - Egitto	2
ET - Etiopia	2
JM - Giamaica	2
NZ - Nuova Zelanda	2
PK - Pakistan	2
TH - Thailandia	2
TW - Taiwan	2
VE - Venezuela	2
XK - ???statistics.table.value.countryCode.XK???	2
AZ - Azerbaigian	1
BO - Bolivia	1
DZ - Algeria	1
GA - Gabon	1
GE - Georgia	1
JO - Giordania	1
KG - Kirghizistan	1
LB - Libano	1
MA - Marocco	1
NO - Norvegia	1
PE - Perù	1
PR - Porto Rico	1
PT - Portogallo	1
QA - Qatar	1
RS - Serbia	1
SI - Slovenia	1
SX - ???statistics.table.value.countryCode.SX???	1
SY - Repubblica araba siriana	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	4.726

Nome	#
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology	1.581
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology	1.362
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology	893
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension	243
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry	240
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology	217
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry	82
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter Study	67
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry	52
Totale	4.737

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	6	0	0	0	0	0	0	0	0	0	4	1	1
2022/2023	23	1	2	2	1	3	1	0	5	1	0	7	0
2023/2024	55	1	2	8	2	3	4	3	0	1	1	16	14
2024/2025	3.442	1	1	14	3	19	18	40	72	33	1.564	1.212	465
2025/2026	1.180	70	146	106	106	97	83	139	54	123	86	73	97
2026/2027	31	31	0	0	0	0	0	0	0	0	0	0	0
Totale													4.737